Mumbai (Maharashtra) [India], February 7: Vaishali Pharma Limited (NSE – VAISHALI), engaged in production and marketing of a diverse range of pharmaceutical products, announced its unaudited Financial Results for Q3 & 9M FY24. Key Financials at a Glance: Q3 FY24 – Total Income at ₹ 28.37 Cr – EBITDA at ₹ 3.42 Cr – EBITDA Margin at 12.05% – […]
Continue Reading
Mumbai (Maharashtra) [India], December 4: Vaishali Pharma Limited, a one of the leading pharmaceutical company based in Mumbai. Company is engaged in the production and marketing of a diverse range of pharmaceutical products. The company recently received a significant order from the African Continent. This development not only signifies the company’s expanding influence but also underscores its growing global reputation and […]
Continue Reading
Mumbai (Maharashtra) [India], November 10: Vaishali Pharma Limited (NSE – VAISHALI), engaged in production and marketing of a diverse range of pharmaceutical products, announced its unaudited Financial Results for H1 & Q2 FY24. Key Financials at a Glance: H1 FY24: • Total Income at ₹ 26.65 Cr • EBITDA at ₹ 5.62 Cr • EBITDA Margin is 21.11 % • Net Profit at ₹ 3.29 Cr • Net Profit Margin is 12.34% • EPS at ₹ 3.10 Q2 […]
Continue Reading